Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-07-29

Clinical Trial Update: A Prospective Dose Finding Study of Iscador Infusion [Phase 1, Phase 2]

View source ↗

Summary

A prospective dose-finding clinical trial evaluating Iscador infusion in advanced cancer patients (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iscador (Viscum album)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Advanced Cancer | Phase 1, Phase 2 | Status: UNKNOWN